Colman is Vice President & General Counsel, North America IP Litigation at Teva Pharmaceuticals, where he focuses on patent litigation in the U.S and Canada, including litigation arising under the Hatch-Waxman. Colman also works closely with both Teva’s Government Affairs department and pharmaceutical trade associations regarding legislative initiatives. Before joining Teva, he was in-house at Allergan plc (formerly Actavis plc). Prior to moving in-house, Colman was an associate at Willkie Farr & Gallagher and Kenyon & Kenyon where his practice focused on Hatch-Waxman litigation for branded, generic, and specialty pharmaceutical companies. He received his J.D. from Benjamin N. Cardozo School of Law, and bachelor’s degrees in both chemistry and Physics from Miami University. Prior to attending law school, Colman was a medicinal chemist in drug discovery at Pfizer, Inc. in Groton, CT. He is also an officer and a member of the board of directors of the NYIPLA